Rimidon 50 Tablet contains Primidone 50mg. 
It is manufactured by Beacon Pharmaceuticals PLC in Bangladesh. 

Indications: Rimidon, used alone or with other anticonvulsants, is indicated in the control of:

• Grand mal seizures (generalized tonic-clonic seizures)  
• Psychomotor seizures (complex partial seizures)  
• Focal epileptic seizures (simple partial seizures)  

It may control grand mal seizures refractory to other anticonvulsant therapy. 

Pharmacology:Primidone raises electro- or chemoshock seizure thresholds or alters seizure patterns in experimental animals. The exact mechanism of its antiepileptic action is not known. Primidone itself has anticonvulsant activity, as do its two metabolites, phenobarbital and phenylethylmalonamide (PEMA). PEMA also enhances the anticonvulsant activity of phenobarbital in experimental animals. 

Dosage and Administration: Dosage should be individualized to provide maximum benefit and should not exceed 2 g daily.

For patients 8 years of age and older with no prior treatment, the following regimen may be used:

• Days 1-3:100 to 125 mg at bedtime.  
• Days 4-6: 100 to 125 mg twice a day.
• Days 7-9:100 to 125 mg three times a day.
• Day 10 to maintenance:250 mg three times a day.  

The usual maintenance dosage for most adults and children 8 years and older is three to four 250 mg tablets daily in divided doses (250 mg three or four times a day). If needed, the dose may be increased to five or six 250 mg tablets daily, but daily doses should not exceed 500 mg four times a day.

Side Effects: The most frequently occurring early side effects are ataxia (lack of coordination) and vertigo (dizziness). These tend to disappear with continued therapy or with a reduction in the initial dosage.

Other occasionally reported side effects include:

• Nausea  
• Anorexia (loss of appetite)
• Vomiting  
• Fatigue
• Hyperirritability
• Emotional disturbances  
• Sexual impotence
• Diplopia (double vision)
• Nystagmus (involuntary eye movement)  
• Drowsiness
• Morbilliform skin eruptions (rash resembling measles)

Rarely reported side effects include granulocytopenia (low white blood cell count), agranulocytosis (severe deficiency of granulocytes), and red-cell hypoplasia and aplasia (bone marrow disorders). Megaloblastic anemia (a type of anemia) may also occur rarely and may respond to folic acid treatment.

Precautions & Warnings: 

• The total daily dosage should not exceed 2 g. 
• Since Rimidon therapy generally extends over prolonged periods, a complete blood count and liver function tests (SMA-12) should be performed every 6 months.  
• Use with caution in patients with depression or suicidal tendencies. Monitor for notable changes in behavior or mood.
• Use with caution in patients with hepatic or renal impairment, respiratory disease, or a history of drug abuse. Potential for drug dependency exists with prolonged use.
• Effects with other sedative drugs or ethanol may be potentiated.  
• Use with caution in debilitated and elderly patients due to potential for paradoxical reactions and cognitive decline.  
• Primidone's active metabolite, phenobarbital, has been associated with cognitive deficits in children receiving chronic therapy.  
• Antiseizure medications should not be discontinued abruptly due to the risk of increased seizure frequency; therapy should be withdrawn gradually.  
• Primidone may cause drowsiness and dizziness; avoid driving or operating machinery until you know how it affects you.  
• Alcohol may increase drowsiness.  
• Birth control pills may not work properly while taking Primidone; discuss alternative methods with your doctor.  
• Pay attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings, and report them to your healthcare provider immediately.  

Contraindications:Rimidon is contraindicated in patients with hypersensitivity to phenobarbital or primidone and in patients with porphyria (a group of genetic disorders that affect the nervous system, skin, or both). 

Pregnancy & Lactation:The effects of Primidone in human pregnancy and nursing infants are unknown.Primidone appears in breast milk in substantial quantities.Due to the potential for somnolence and drowsiness in nursing newborns, discontinuation of nursing may be suggested if the mother is treated with Primidone. 

Storage Conditions: Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Important Note: This information is for general knowledge and informational purposes only and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.